News
12 Health Care Stocks Moving In Tuesday's After-Market Session
26 Mar 24
Movers
United Therapeutics Announces $1B Accelerated Share Repurchase Program
25 Mar 24
Biotech, News, Health Care, Buybacks, General
United Therapeutics Filed Motion In U.S. District Court For The District Of Delaware For Preliminary Injunction In Its Patent Litigation With Liquidia Technologies' Efforts To Seek FDA Approval For PH-ILD For Its Inhaled Treprostinil Product-8K
27 Feb 24
Biotech, News, Health Care, Legal, General
Beyond The Numbers: 4 Analysts Discuss United Therapeutics Stock
22 Feb 24
Analyst Ratings
Wedbush Reiterates Outperform on United Therapeutics, Maintains $308 Price Target
22 Feb 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on United Therapeutics, Maintains $300 Price Target
22 Feb 24
News, Price Target, Reiteration, Analyst Ratings
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
21 Feb 24
Biotech, Earnings, Large Cap, News, Health Care, FDA, Legal, General
United Therapeutics Q4 GAAP EPS $4.36 Beats $4.19 Estimate, Sales $614.70M Beat $575.87M Estimate
21 Feb 24
Earnings, News
Earnings Scheduled For February 21, 2024
21 Feb 24
Earnings
Earnings Outlook For United Therapeutics
20 Feb 24
Earnings
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
12 Feb 24
Analyst Color, News, Upgrades, Price Target, Small Cap, Top Stories, Analyst Ratings, Movers, Trading Ideas
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday
12 Feb 24
News, Price Target, Small Cap, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas
Goldman Sachs Upgrades United Therapeutics to Neutral, Raises Price Target to $215
12 Feb 24
News, Upgrades, Price Target, Analyst Ratings
Leerink Partners Initiates Coverage On United Therapeutics with Outperform Rating, Announces Price Target of $330
5 Feb 24
News, Price Target, Initiation, Analyst Ratings
Press releases
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
16 Apr 24
Press Releases
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
25 Mar 24
Press Releases
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024
5 Mar 24
Press Releases
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
Press Releases
United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process
21 Feb 24
Press Releases
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024
14 Feb 24
Press Releases